The Effıcacy of Pulmonary Rehabılıtatıon in Patıents Copd Usıng Long-Term Oxygen Therapy

Year 2018, Volume: 71 Issue: 1, 47 - 53, 16.10.2018

İpek Candemir

Abstract

Introduction: Pulmonary rehabilitation (PR) has also been shown to be an effective approach in COPD pateients using long-term oxygen therapy (LTOT). In this study, it was aimed to investigate the factors that might determine the effectiveness of PR program in patients with advanced COPD using LTOT with chronic hypoxemic respiratory failure.

Method: The datas of patients with spirometric stage 3-4 COPD who completed a comprehensive multidipliner PR program, were investigated retrospectively. Patients with systolic pulmonary artery pressure ≤ 36 mmHg according to echocardiographic evaluation and 19 patients with LTOT (Group I) and 21 patients without exertional desaturation and resting hypoxemia (Group II), were included to the study. The subjects were divided into two groups according to the using LTOT. The values of MRC score, the S. George quality of life questionnaire (SGRQ), incremental shuttle walking test (ISWT) and endurance shuttle walking test (ESWT), body mass and fat-free mass index (BMI, FFMI) performing before and after PR were recorded. The relationship between baseline values before PR and the gainings of PR program was examined.

Results: Mean value of age was 61±5 year with mean value of FEV1 predicted 32 ±8%. MRC, SGRQ scores and ISWT distances were improved after PR in both groups and the improvements were smiliar between groups. In group I, baseline FEV1 predicted % was not found to be correlated with improvements in exercise capacity and quality of life. In this group the improvements in sensation of dyspnea was found to be less in those with a higher baseline MRC score [ΔMRC with MRC (p = 0.015, r = -0.550)]. In the group II, there was a significant correlation between baseline FEV1 predicted% and ΔSGRQ total score (p=0,014, r=0,526), between MRC and ΔMRC (p =0.008, r=-0.565), ΔSGRQ activity and total score (respectively p=0,010, r=0,551 /p=0,017, r=0,516), ΔISWT (p=0,006, r=-0,574).

Conclusion: Multidisciplinary, comprehensive, outpatients supervised PR program was found to be an effective approach in advanced stage COPD with LTOT as smilar as patients without LTOT and improvements in exercise capacity and quality of life were not shown to be influenced by level of loss in pulmonary function and furthermore in patients who were more dyspneic, the improvements in sensation of dyspnea were found to be less.

Keywords

COPD , dyspnea , LTOT , exercise capacity , quality of life , PR

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

Spirometrik İleri Evre Usot Kullanan Koah Tanılı Olgularda Pulmoner Rehabilitasyon Etkinliği

Abstract

Giriș:Pulmoner rehabilitasyonun (PR) uzun süreli oksijen tedavisi (USOT) kullanan KOAH tanılı olgularda da etkin bir yaklașım olduğu gösterilmiștir. Bu çalıșmada kronik hipoksemik solunum yetmezliği tanısıyla USOT kullanan ileri evre KOAH’lı olgularda PR program etkinliğinde belirleyici olabilecek faktörlerin araștırılması amaçlanmıștır.

Metod: Multidipliner, kapsamlı, ayaktan PR programını tamamlayan GOLD spirometrik evre 3-4 KOAH tanılı olguların verileri retrospektif olarak incelenmiștir. Transtorasik ekokardiyografide sistolik pulmoner arter basıncı (SPAP) ≤ 36 mmHg olan, USOT kullanan 19 olgu (Grup I) istirahat ve egzersiz hipoksemisi olmayan USOT kullanmayan 21 olgu (GrupII) çalıșmaya dahil edilmiștir. Olguların PR programı önce ve sonrası Medical research council (MRC) dispne skalası, S. George respiratory questionary (SGRQ), artan hızda mekik yürüme testi (AHMYT) ve endurans mekik yürüme testi (EMYT), vücut kitle ve yağsız vücut kitle indeksi (VKİ, YVKİ) değerleri kaydedilmiștir. PR öncesi bașlangıç değerlendirme verileri ile PR programı sonrası kazanımlar arasındaki ilișki incelenmiștir.

Bulgular: Olguların yaș ortalaması 61±5 yıl ve FEV1 ortalaması beklenenin %32 ±8’di. Her iki grupta PR sonrası MRC, SGRQ toplam ve alt skorları, AHMYT sonuçlarında istatistiksel anlamlı değișim izlenmiș olup her iki grupta da kazanımların benzer düzeylerde olduğu görülmüștür. Grup I’de PR sonrası kazanımlar solunum fonksiyonları, yașam kalitesi, egzersiz kapasitesi bașlangıç düzeyleri ile anlamlı korelasyon bulunmazken bașlangıç dispne algısı yüksek olanlarda dispne algısındaki iyileșmenin daha az olduğu görülmüștür [MRC ile ΔMRC (p =0.015, r=-0.550)]. Grup II’de bașlangıç ortalama FEV1 %’si ile ΔSGRQ toplam skor arasında (p=0,014, r=0,526) , MRC ile ΔMRC (p =0.008, r=-0.565), ΔSGRQ aktive ve toplam skoru (sırasıyla p=0,010, r=0,551 /p=0,017, r=0,516), ΔAHMYT (p=0,006, r=-0,574) arasında anlamlı korelasyon bulunmuștur.

Sonuç: USOT kullanan ileri evre KOAH tanılı olgularda multidisipliner, kapsamlı, ayaktan direkt gözetimli PR programlarının USOT kullanmayan olgularla benzer șekilde etkin bir yaklașımdır. Ayrıca, kazanımların solunum fonksiyonlarındaki kayıp düzeyi, egzersiz kapasitesi ve yașam kalitesi düzeylerinden etkilenmediği görülürken bașlangıç değerlendirmesinde dispne algısı yüksek olanlarda dispne algısındaki iyileșmenin daha az olduğu görülmüștür

Keywords

KOAH , dispne , USOT , egzersiz kapasitesi , yașam kalitesi , pulmoner rehabilitasyon

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

• 1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http://goldcopd.org
• 2. Wells JM, Estepar RSJ, McDonald MN, et al. Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. BMC Pulm Med 2016; 16:169.
• 3. Vold ML, Aasebo U, Hjalmarsen A, et al. Predictors of oxygen saturation 95% in a cross-sectional population based survey. Respir Med 2012; 106:1551–1558.
• 4. Stoller JK, Aboussouan LS, Kanner RE, et al. LOTT Research Group. Characteristics of alpha-1 antitrypsin- deficient individuals in the long-term oxygen treatment trial and comparison with other subjects with chronic obstructive pulmonary disease. Ann Am Thorac Soc 2015; 12:1796– 1804.
• 5. Andrianopoulos V, Celli BR, Franssen FM, et al. Determinants of exercise- induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study. Respir Med 2016; 119:87– 95.
• 6. Antonucci R, Berton E, Huertas A, et al. Exercise physiology in COPD. Monaldi Arch Chest Dis. 2003;59:134–139.
• 7. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–1385.
• 8. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:637–658.
• 9. Vanier T, Dulfano J, Wu C, et al. Emphysema, hypoxia and the polycythemic response. N Engl J Med. 1963;269:169–178.
• 10. Garcia-Aymerich J, Monso E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001;164:1002– 1007.
• 11. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;133:14–20.
• 12. Harris CS, Bishop JM, Clark JH, et al. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981;1:681–686.
• 13. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: 13-64.
• 14. Boutou AK, Shrikrishna D, Tanner RJ, et al. Lung function indices for predicting mortality in COPD. Eur Respir J 2013; 42:616–625.
• 15. McDonald ML, Cho MH, Sorheim IC, et al. Common genetic variants associated with resting oxygena- tion in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2014; 51:678–687.
• 16. Hardinge M, Annandale J, Bourne S, et al. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015; 70:1–43.
• 17. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from American College of Physicians, American Collage of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155:179–191.
• 18. Bettoncelli G, Blasi F, Brusasco V, et al. The clinical and integrated management of COPD. An official document of AIMAR (Inter disciplinary Association of Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Multidiscip Respir Med 2014; 9:1-25.
• 19. Kocabas A, Atıs S, Çöplü L, ve ark. Kronik obstrüktif akciger hastalıgı (KOAH) koruma, tanı ve tedavi raporu 2014. Turkish Thoracic Journal 2014; 2:68– 71.
• 20. Ortega Ruiz F, Diaz Lobato S, Galdiz Iturri JB, et al.Continuous home oxygen therapy. Arch Bronconeumol 2014; 50:185–200.
• 21. Romer LM, Haverkamp HC, Amann M, et al. Effect of acute severe hypoxia on peripheral fatigue and endurance capacity in healthy humans. Am J Physiol Regul Integr Comp Physiol. 2007; 292(1):598-606.
• 22. Saglam M, Vardar-Yagli, Savci S, et al. Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2015; 26;10:423-8.
• 23. Kim V, Benditt JO, Wise RA, et al. A.Oxygen therapy in chronic obstructive pulmonary disease.Proc Am ThoracSoc. 2008; 5:513-8.
• 24. Jolly EC, Di Boscio V, Aguirre L, et al. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest 2001; 120:437–443.
• 25. Ameer F, Carson KV, Usmani ZA, et al. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev 2014; 6:CD000238.
• 26. Ergan B, Nava S. Long-Term Oxygen Therapy in COPD Patients Who Do Not Meet the Actual Recommendations. COPD. 2017;14:351-366.
• 27. Vagaggini B, Costa F, Antonelli S, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med. 2009;103:1224-30.
• 28. Greulich T, Koczulla AR, Nell C, et al. Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective Analysis. Respiration. 2015;90:287-92
• 29. Sahin H, Varol Y, Naz I, et al. Effectiveness of pulmonary rehabilitation in COPD patients receiving long-term oxygen therapy.. Clin Respir J. 2017. doi: 10.1111/crj.12680.
• 30. Vagaggini B, Costa F, Antonelli S, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med 2009;103:1224–1230.
• 31. Evans RA, Singh SJ, Collier R, et al. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respiratory medicine 2009; 103: 1070-1075.
• 32. Jacome C, Marques A. Impact of pulmonary rehabilitation in subjects with mild COPD. Respiratory care 2014; 59: 1577- 1582.
• 33. Jacome C, Marques A. Pulmonary rehabilitation for mild COPD: a systematic review. Respiratory care 2014; 59: 588-594
• 34. Schroff P, Hitchcock J, Schumann C, et al. Pulmonary Rehabilitation Improves Outcomes in Chronic Obstructive Pulmonary Disease Independent of Disease Burden. Ann Am Thorac Soc. 2017;14:26-32.
• 35. Alfarroba S, Rodrigues F, Papoila AL, et al. Pulmonary Rehabilitation in COPD According to Global Initiative for Chronic Obstructive Lung Disease Categories. Respir Care. 2016;61:1331-40.
• 36. Garrod R, Marshall J, Barley E, et al. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 2006; 27: 788– 794.
• 37. Zanini A, Chetta A, Gumiero F, et al. Sixminute walking distance improvement after pulmonary rehabilitation is associated with baseline lung function in complex COPD patients: a retrospective study. Biomed Res Int 2013;13:48-62.
• 38. Vagaggini B, Costa F, Antonelli S, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med 2009; 103:1224–1230.
• 39. Greulich T, Koczulla AR, Nell C, et al. Effect of a Three-Week Inpatient Rehabilitation Program on 544 Consecutive Patients with Very Severe COPD: A Retrospective Analysis. Respiration. 2015;90:287-92.